Interventional Oncology Devices | Market Insights | Asia Pacific (Supplemental) | 2022
Despite the negative—albeit relatively limited—impact of the ongoing COVID-19 pandemic, the Asia Pacific interventional oncology device market will see strong growth through 2030 driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of new competitors. However, a lack of reimbursement and pricing pressures will remain a challenge.
This Medtech 360 Report provides high-level market metrics for devices used in interventional oncology in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across an 11-year period.
